The specific variants analysed here—SMAD3 rs17293632 and LTBP3 rs11545200—may affect pathways critical for mucosal immunity, tissue remodeling, and TGF-β signaling, all of which are central to IBD pathogenesis (Figure 1) [36]. Here, LTBP3 is linked to inflammatory bowel disease.